The GNS Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population generated from the Jurkat human T-lymphocyte line, designed for targeted disruption of the GNS gene. GNS encodes the lysosomal enzyme glucosamine-6-sulfatase, critical for heparan sulfate and keratan sulfate degradation. This polyclonal model provides a heterogeneous yet consistent system for dissecting glycosaminoglycan (GAG) catabolism in a T-cell context, supporting investigations into lysosomal storage and immune cell pathophysiology.
Jurkat cells, an immortalized human T-cell leukemia line, are extensively employed in immunological research to study T-cell receptor (TCR) signaling, cytokine production, and programmed cell death. Their suspension growth, rapid doubling time, and susceptibility to CRISPR/Cas9 editing make them an ideal platform for generating gene knockouts. The Jurkat background offers a well-characterized and physiologically relevant model for exploring how lysosomal dysfunction impacts T-lymphocyte biology and immune responses.
The GNS gene product, lysosomal glucosamine-6-sulfatase, catalyzes the hydrolysis of 6-sulfate groups from N-acetyl-D-glucosamine 6-sulfate residues within heparan sulfate (HS) and keratan sulfate (KS) chains. This enzymatic reaction is a key step in the sequential degradation of GAGs. GNS activity is post-translationally activated by the formylglycine-generating enzyme SUMF1 and is functionally linked to other sulfatases such as SGSH. Upstream, the transcription factor TFEB and the mTORC1 complex regulate GNS expression and lysosomal biogenesis in response to HS fragment accumulation. Downstream, loss of GNS leads to lysosomal storage of undegraded HS and KS, which in turn triggers alterations in autophagy-related proteins, such as LC3-II and p62, and promotes secretion of inflammatory cytokines. The GNS pathway intersects with HGSNAT, NAGLU, and IDUA in the catabolism of heparan sulfate.
Disruption of GNS in Jurkat T lymphocytes impairs GAG degradation, leading to lysosomal engorgement and cellular stress. This recapitulates features of mucopolysaccharidosis type IIID (Sanfilippo D syndrome) and compromises TCR signaling, cytokine release, and apoptotic pathways. The polyclonal knockout population allows researchers to investigate how accumulated GAGs affect T-cell activation, differentiation, and immune homeostasis, providing a bridge between lysosomal storage disorders and immunology.
Typical research applications include mechanistic dissection of lysosomal storage diseases, investigation of GAG turnover in T cells, and high-throughput drug screening for Sanfilippo D syndrome. Researchers can confirm GNS ablation by Western blotting, measure residual sulfatase activity using fluorogenic substrates, quantify HS/KS accumulation via ELISA or LC-MS, and monitor lysosomal changes through immunofluorescence for LAMP1 and flow cytometric lysosomal mass assays. Additional functional assays??autophagy flux analysis, cytokine profiling, and apoptosis assessment??reveal downstream cellular consequences. For further information, please contact Ascent Research.
